eprintid: 10202579
rev_number: 7
eprint_status: archive
userid: 699
dir: disk0/10/20/25/79
datestamp: 2024-12-20 10:32:17
lastmod: 2024-12-20 10:32:17
status_changed: 2024-12-20 10:32:17
type: article
metadata_visibility: show
sword_depositor: 699
creators_name: Denton, Christopher P
title: Comment on: The 2024 British Society for Rheumatology guideline for management of systemic sclerosis. Reply
ispublished: inpress
divisions: UCL
divisions: B02
divisions: C10
divisions: D17
divisions: G90
note: This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.
date: 2024-12-04
date_type: published
publisher: Oxford University Press (OUP)
official_url: https://doi.org/10.1093/rheumatology/keae659
full_text_type: other
language: eng
verified: verified_manual
elements_id: 2343319
doi: 10.1093/rheumatology/keae659
lyricists_name: Denton, Christopher
lyricists_id: CPDEN87
actors_name: Denton, Christopher
actors_id: CPDEN87
actors_role: owner
full_text_status: restricted
publication: Rheumatology
citation:        Denton, Christopher P;      (2024)    Comment on: The 2024 British Society for Rheumatology guideline for management of systemic sclerosis. Reply.                   Rheumatology        10.1093/rheumatology/keae659 <https://doi.org/10.1093/rheumatology%2Fkeae659>.    (In press).   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10202579/1/Denton-REPLY%20to%20letter%202024-BSR%20SSc%20GL-accepted.pdf